Glintborg, B, Jensen, D V, Terslev, L, Hendricks, O, Østergaard, M, Rasmussen, S H, Jensen, M P, Adelsten, T, Colic, A, Danebod, K, Kildemand, M, Loft, A G, Munk, H L, Pedersen, J K, Østgård, R D, Sørensen, C M, Krogh, N S, Agerbo, J N, Ziegler, C & Hetland, M L 2022, ' Long-term Behavioral Changes During the COVID-19 Pandemic and Impact of Vaccination in Patients With Inflammatory Rheumatic Diseases ', Journal of Rheumatology, vol. 49, no. 10, pp. 1163-1172 . https://doi.org/10.3899/jrheum.211280
Nabi, H, Hendricks, O, Jensen, D V, Loft, A G, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Chrysidis, S, Raun, J L, Andersen, M, Mehnert, F, Krogh, N S, Hetland, M L & Glintborg, B 2022, ' Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease : clinical outcomes in real-world patients from the DANBIO registry ', RMD Open, vol. 8, no. 2, e002560 . https://doi.org/10.1136/rmdopen-2022-002560 Nabi, H, Hetland, M L, Loft, A G, Hendricks, O, Jensen, D, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Grydehøj, J, Raun, J, Ahmed, R, Mehnert, F, Krogh, N S & Glintborg, B 2022, ' INFLIXIMAB BIOSIMILAR-TO-BIOSIMILAR SWITCHING IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: CLINICAL OUTCOMES IN REAL-WORLD PATIENTS FROM THE DANBIO REGISTRY ', Annals of the Rheumatic Diseases, vol. 81, no. Suppl. 1, OP0065, pp. 45-46 . https://doi.org/10.1136/annrheumdis-2022-eular.2306 Nabi, H, Hendricks, O, Jensen, D V, Loft, A G, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Chrysidis, S, Raun, J L, Andersen, M, Mehnert, F, Krogh, N S, Hetland, M L & Glintborg, B 2022, ' Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease : Clinical outcomes in real-world patients from the DANBIO registry ', RMD Open, vol. 8, no. 2, 002560 . https://doi.org/10.1136/rmdopen-2022-002560 Nabi, H, Hendricks, O, Jensen, D V, Loft, A G, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Chrysidis, S, Raun, J L, Andersen, M, Mehnert, F, Krogh, N S, Hetland, M L & Glintborg, B 2022, ' Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease : Clinical outcomes in real-world patients from the DANBIO registry ', RMD open, vol. 8, no. 2, 002560 . https://doi.org/10.1136/rmdopen-2022-002560
Glintborg, B, Jensen, D V, Terslev, L, Jensen, M P, Hendricks, O, Østergaard, M, Engel, S, Rasmussen, S H, Adelsten, T, Colic, A, Danebod, K, Kildemand, M, Loft, A G, Munk, H L, Pedersen, J K, Østgård, R D, Sørensen, C M, Krogh, N S, Agerbo, J N, Ziegler, C & Hetland, M L 2021, ' Impact of the COVID-19 pandemic on treat to target strategies and physical consultations in > 7000 patients with inflammatory arthritis ', Rheumatology, vol. 60, no. SI, pp. SI3-SI12 . https://doi.org/10.1093/rheumatology/keab500 BASE-Bielefeld Academic Search Engine Rheumatology (Oxford, England) Glintborg, B, Jensen, D V, Terslev, L, Pfeiffer Jensen, M, Hendricks, O, Østergaard, M, Engel, S, Horskjær Rasmussen, S, Adelsten, T, Colic, A, Danebod, K, Kildemand, M, Loft, A G, Munk, H L, Pedersen, J K, Østgård, R D, Møller Sørensen, C, Krogh, N S, Nørgaard Agerbo, J, Ziegler, C & Hetland, M L 2021, ' Impact of the COVID-19 pandemic on treat-to-target strategies and physical consultations in >7000 patients with inflammatory arthritis ', Rheumatology (Oxford, England), vol. 60, no. SI, pp. SI3-SI12 . https://doi.org/10.1093/rheumatology/keab500
Glintborg, B, Jensen, D V, Engel, S, Terslev, L, Pfeiffer Jensen, M, Hendricks, O, Østergaard, M, Horskjær Rasmussen, S, Adelsten, T, Colic, A, Danebod, K, Kildemand, M, Loft, A G, Munk, H L, Pedersen, J K, Østgård, R D, Møller Sørensen, C, Krogh, N S, Nørgaard Agerbo, J, Ziegler, C & Lund Hetland, M 2021, ' Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry ', RMD Open, vol. 7, no. 2, e001649 . https://doi.org/10.1136/rmdopen-2021-001649 RMD Open RMD Open, Vol 7, Iss 2 (2021)
RMD Open Glintborg, B, Jensen, D V, Engel, S, Terslev, L, Pfeiffer Jensen, M, Hendricks, O, Ostergaard, M, Horskjær Rasmussen, S, Adelsten, T, Colic, A, Danebod, K, Kildemand, M, Loft, A G, Munk, H L, Pedersen, J K, Østgård, R D, Møller Sørensen, C, Krogh, N S, Agerbo, J, Ziegler, C & Hetland, M 2021, ' Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic : Results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry ', RMD Open, vol. 7, no. 1, 001505 . https://doi.org/10.1136/rmdopen-2020-001505 Glintborg, B, Jensen, D V, Engel, S, Terslev, L, Pfeiffer Jensen, M, Hendricks, O, Ostergaard, M, Horskjær Rasmussen, S, Adelsten, T, Colic, A, Danebod, K, Kildemand, M, Loft, A G, Munk, H L, Pedersen, J K, Østgård, R D, Møller Sørensen, C, Krogh, N S, Agerbo, J, Ziegler, C & Hetland, M 2021, ' Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic : results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry ', RMD Open, vol. 7, no. 1, e001505 . https://doi.org/10.1136/rmdopen-2020-001505 RMD Open, Vol 7, Iss 1 (2021)
Glintborg, B, Georgiadis, S, Loft, A G, Linauskas, A, Lindegaard, H, Hendricks, O, Jensen, D V, Andersen, B L, Danebod, K, Villumsen, A, Eng, G, Wiell, C, Manilo, N, Kristensen, S, Raun, J, Grydehøj, J, Chrysidis, S, Nørgaard, M, Mehnert, F, Krogh, N S & Hetland, M L 2020, ' Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4) : an observational nationwide study applying linkage between DANBIO and national registries ', Annals of the Rheumatic Diseases, vol. 79, no. 6, pp. 846-848 . https://doi.org/10.1136/annrheumdis-2019-216702 Glintborg, B, Georgiadis, S, Loft, A G R, Linauskas, A, Lindegaard, H, Hendricks, O, Jensen, D V, Lange Andersen, B, Danebod, K, Villumsen, A, Eng, G, Wiell, C, Manilo, N, Kristensen, S, Raun, J L, Grydehøj, J, Chrysidis, S, Nørgaard, M, Mehnert, F, Krogh, N S & Lund Hetland, M 2020, ' Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries ', Annals of the Rheumatic Diseases, bind 79, nr. 6 . https://doi.org/10.1136/annrheumdis-2019-216702 Glintborg, B, Georgiadis, S, Loft, A G, Linauskas, A, Lindegaard, H, Hendricks, O, Jensen, D V, Andersen, B L, Danebod, K, Villumsen, A, Eng, G, Wiell, C, Manilo, N, Kristensen, S, Raun, J, Grydehøj, J, Chrysidis, S, Nørgaard, M, Mehnert, F, Krogh, N S & Hetland, M L 2020, ' Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4) : An observational nationwide study applying linkage between DANBIO and national registries ', Annals of the rheumatic diseases, vol. 79, no. 6, pp. 846-848 . https://doi.org/10.1136/annrheumdis-2019-216702
Glintborg, B, Loft, A G, Omerovic, E, Hendricks, O, Linauskas, A, Espesen, J, Danebod, K, Jensen, D V, Nordin, H, Dalgaard, E B, Chrysidis, S, Kristensen, S, Raun, J L, Lindegaard, H, Manilo, N, Jakobsen, S H, Hansen, I M J, Pedersen, D D, Sørensen, I J, Andersen, L S, Grydehøj, J, Mehnert, F, Krogh, N S & Lund Hetland, M 2020, ' Response to ''To switch or not to switch' : the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al ', Annals of the Rheumatic Diseases, vol. 79, no. 4, e37 . https://doi.org/10.1136/annrheumdis-2018-214952 Glintborg, B, Loft, A G, Omerovic, E, Hendricks, O, Linauskas, A, Espesen, J, Danebod, K, Jensen, D V, Nordin, H, Dalgaard, E B, Chrysidis, S, Kristensen, S, Raun, J L, Lindegaard, H, Manilo, N, Jakobsen, S H, Hansen, I M J, Pedersen, D D, Sørensen, I J, Andersen, L S, Grydehøj, J, Mehnert, F, Krogh, N S & Lund Hetland, M 2020, ' Response to To switch or not to switch' : The missing piece in the puzzle of biosimilar literature?' by Scherlinger et al ', Annals of the Rheumatic Diseases, vol. 79, no. 4, e37 . https://doi.org/10.1136/annrheumdis-2018-214952 Glintborg, B, Loft, A G, Omerovic, E, Hendricks, O, Linauskas, A, Espesen, J, Danebod, K, Jensen, D V, Nordin, H, Dalgaard, E B, Chrysidis, S, Kristensen, S, Raun, J L, Lindegaard, H, Manilo, N, Jakobsen, S H, Hansen, I M J, Pedersen, D D, Sørensen, I J, Andersen, L S, Grydehøj, J, Mehnert, F, Krogh, N S & Lund Hetland, M 2020, ' Response to ''To switch or not to switch' : the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al ', Annals of the Rheumatic Diseases, vol. 79, no. 4 . https://doi.org/10.1136/annrheumdis-2018-214952